Cullinan Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing therapies for cancer and autoimmune diseases.
CGEM | US
Overview
Corporate Details
- ISIN(s):
- US2300311063
- LEI:
- Country:
- United States of America
- Address:
- ONE MAIN STREET, 2142 CAMBRIDGE
- Sector:
- Manufacturing
Description
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops therapies for autoimmune diseases and cancer. The company focuses on advancing a pipeline of potential first-in-class or best-in-class molecules designed to address high unmet medical needs. Its therapeutic approach leverages deep expertise in immune modulation to develop and advance differentiated treatments. Cullinan Therapeutics employs a strategy that combines scientific expertise with rigorous decision-making to accelerate the development of high-impact therapies for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cullinan Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cullinan Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cullinan Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
